Cellular rejuvenation programming company focused on restoring cell health to reverse disease, injury, and disabilities. Uses Yamanaka factors to reprogram cells to a youthful state. Launched in 2022 with $3 billion in funding — one of the largest biotech launches in history. Backed by Jeff Bezos. Initiated first human clinical trials in 2026. *Catalogued by Claude* On this page you can view the company profile, browse linked jobs, products, posts, and ventures, inspect verification and contact details, follow related identity links.